 |
 | Services
| |
 |
Aliases & Descriptions for FAH
(According to
1HGNC,
2Entrez Gene,
3UniProtKB/Swiss-Prot,
4UniProtKB/TrEMBL, 5OMIM, 6GeneLoc
, and/or 7Ensembl,
8miRBase) About This Section
|
| Aliases |
|---|
| Beta-diketonase 3 | | EC 3.7.1.2 3 | | FAA 3 | | fumarylacetoacetase 2 |
| | | Descriptions |
|---|
| Fumarylacetoacetate hydrolase 3 | | fumarylacetoacetate hydrolase (fumarylacetoacetase) 2 | | tyrosinaemia type I 2 |
|
| | Search outside databases for aliases for FAH genePrevious GC identifers: GC15P076401 GC15P073602 GC15P078021 GC15P078161 |
Summaries for FAH(According to Entrez Gene,
Wikipedia's
Gene Wiki,
UniProtKB/Swiss-Prot,
and/or
UniProtKB/TrEMBL)
About This Section
| EntrezGene summary for FAH: This gene encodes the last enzyme in the tyrosine catabolism pathway. FAH deficiency is associated with Type 1 hereditary tyrosinemia (HT). [provided by RefSeq]
|
Genomic Location for FAH
(According to
GeneLoc and/or
HGNC, and/or
Entrez Gene (NCBI build 36),
and/or miRBase,
Genomic Views according to
UCSC and
Ensembl,
Transcription factor binding sites according to
SABiosciences) About This Section
| Genomic View: UCSC Golden Path with GeneCards custom track
Transcription factor binding sites upstream to the FAH gene 
Entrez Gene cytogenetic band: 15q23-q25 Ensembl cytogenetic band: 15q25.1 HGNC cytogenetic band: 15q23-q25FAH Gene in genomic location: bands according to Ensembl, locations according to
(and/or Entrez Gene and/or Ensembl if different)
 GeneLoc gene densities for chromosome 15 GeneLoc Exon Structure GeneLoc location for GC15P078232:
(about GC identifiers)
Start:
|
78,232,177 bp from pter |
End:
|
78,266,343 bp from pter |
Size:
|
34,167 bases |
Orientation:
|
plus strand |
RefSeq DNA sequence:- NC_000015.8 NT_010194.16
| Proteins for FAH
(According to
1UniProtKB,
and/or Ensembl,
Phosphorylation sites according to 2Phosphosite,
RefSeq according to NCBI,
PDB rendering according to OCA and/or Proteopedia,
Recombinant Proteins
from Invitrogen,
Millipore,
Sigma-Aldrich,
R&D Systems,
Enzo Life Sciences,
Abnova,
OriGene and/or,
Abcam,
Biochemical Assays by
Invitrogen,
Millipore,
R&D Systems,
Cell Signaling Technology, and/or
Enzo Life Sciences,
Ontologies according to Gene
Ontology Consortium 01 Apr 2009 and
Entrez Gene,
Antibodies by Invitrogen,
Millipore,
Sigma-Aldrich,
R&D Systems,
Cell Signaling Technology,
Abcam,
Abnova, and/or
Novus Biologicals)
About This Section
| UniProtKB/Swiss-Prot: FAAA_HUMAN, P16930 (See
protein sequence)Recommended Name: Fumarylacetoacetase Size: 419 amino acids; 46374 Da
Cofactor: Calcium (By similarity)
Cofactor: Magnesium (By similarity)
Subunit: HomodimerPost-translational modifications:
View phosphorylation sites using PhosphoSite2
REFSEQ proteins: NP_000128.1
ENSEMBL proteins: ENSP00000261755 ENSP00000385080
Human Recombinant Proteins               OriGene Purified Recombinant Human Protein: FAH 
1 Gene Ontology (GO) cellular component term (links to tree view): About this table
Antibodies for FAH: Assays for FAH: | Protein
Domains/ Families for FAH(According to InterPro, ProtoNet,
UniProtKB, and/or BLOCKS,
Sets of similar genes according to GeneDecks)
About This Section
| - Graphical View of Domain Structure for InterPro Entry P16930
ProtoNet protein and cluster: P16930 1 Blocks protein family: IPB002529 Fumarylacetoacetate (FAA) hydrolase
UniProtKB/Swiss-Prot: FAAA_HUMAN, P16930Similarity: Belongs to the FAH family | Gene Function for FAH
(According to MGI Jun 06 2009, UniProtKB,
IUBMB,and/or Genatlas,
shRNA from
OriGene,
Sigma-Aldrich, RNAi from
Sigma-Aldrich,
RNAi Products,
Clones, and
Q-PCR Products
from Invitrogen,
Millipore,
OriGene, and/or
Abnova,
siRNAs from
Applied Biosystems,
SYBR primers from OriGene,
Cell-based Assays from Millipore,
Ontologies according to Gene Ontology Consortium 01 Apr 2009 via
Entrez Gene.)
About This Section
|               OriGene 29mer shRNA kit in GFP-retroviral vector: NM_000137
Applied Biosystems Silencer® siRNAs for FAH
Sigma-Aldrich siRNA and siRNA Panels for FAH  Sigma-Aldrich shRNA for FAH  Explore Sigma-Aldrich super-pooled esiRNAs 
              OriGene GFP tagged cDNA clone in CMV expression vector: NM_000137                                  Myc/DDK tagged cDNA clone in CMV expression vector: NM_000137                                  untagged cDNA clone in CMV expression vector: NM_000137 
Primers: Browse
Quantitative PCR Central at Invitrogen for Q-PCR LUX™ Primers               OriGene genome-wide validated SYBR primer pairs: NM_000137
UniProtKB/Swiss-Prot: FAAA_HUMAN, P16930Catalytic activity: 4-fumarylacetoacetate + H(2)O = acetoacetate + fumarateEnzyme Number (IUBMB): EC 3.7.1.2 Genatlas biochemistry entry for FAH:fumarylacetoacetate hydrolase,catalyzing the fifth step of tyrosine catabolism7 MGI mutant phenotypes (inferred from 3 alleles ) (MGI details for Fah):
4 Gene Ontology (GO) molecular function terms (links to tree view): About this table | Pathways & Interactions for FAH
(Pathways according to Invitrogen
(maps by GeneGo),
Millipore,
Cell Signaling Technology,
Sigma-Aldrich,
KEGG
and/or UniProtKB,
Sets of similar genes according to GeneDecks,
Proteins Network according to
SABiosciences,
Interactions according to 1UniProtKB,
2MINT, and/or
3STRING,
with links to IntAct and
Ensembl,
Ontologies according to Gene Ontology Consortium 01 Apr 2009 via
Entrez Gene.)
About This Section
| 1 Sigma-Aldrich "Your Favorite Gene" Pathway for FAH (Your Favorite Gene powered by Ingenuity) 
UniProtKB/Swiss-Prot: FAAA_HUMAN, P16930Pathway: Amino-acid degradation; L-phenylalanine degradation; acetoacetic acid and fumarate from L-phenylalanine: step 6/6 5/12 Interacting proteins for FAH (ENSP000002617553) via UniProtKB, MINT, and/or STRING (see all 12
)About this table
5 Gene Ontology (GO) biological process terms (links to tree view): About this table
|
Drugs & Compounds for FAH(Chemical Compounds according to UniProtKB, Enzo Life Sciences,
Sigma-Aldrich, Tocris Bioscience, and/or
Novoseek and Drugs according to
Enzo Life Sciences and/or
PharmGKB)
About This Section
|
Browse Tocris compounds for FAH 10/11 Novoseek chemical compound relationships for FAH gene (see all 11
)
| Compound |
Score |
Articles |
PubMed IDs for Articles with Shared Sentences (# sentences) |
| fumarylacetoacetate |
99.37 |
162 |
11196105 (4), 1741389 (3), 1998338 (3), 12203990 (2) (see all 82) |
| maleylacetoacetate |
91.32 |
2 |
9305902 (1), 15531838 (1) |
| ntbc |
88.31 |
1 |
16492973 (1) |
| homogentisate |
73.92 |
2 |
17513424 (1), 7568087 (1) |
| tyrosine |
68.30 |
63 |
8253377 (2), 1644288 (2), 12944177 (2), 2014797 (1) (see all 37) |
| acetoacetate |
58.10 |
7 |
10508789 (1), 15934927 (1), 11154690 (1), 17064256 (1) |
| bgl ii |
51.29 |
1 |
1350265 (1) |
| mspi |
50.11 |
2 |
1722306 (1) |
| rsai |
47.32 |
2 |
1674379 (1) |
| phenylalanine |
46.61 |
3 |
10508789 (1), 7568087 (1) |
About this table
|
Transcripts for FAH(GenBank/EMBL/DDBJ Accessions according to
Unigene
(Build 219 Homo sapiens; Jun 2 2009) or GenBank, RefSeq according to Entrez Gene,
DOTS (version 10), and/or
AceView,
non coding RNAs according to
RNAdb,
ESTs according to GeneTide,
exon structure from GeneLoc,
alternative splicing isoforms according to ASD and/or
ECgene,
RNAi Products from Invitrogen,
Millipore, and/or
Abnova,
siRNAs from Applied Biosystems,
Sigma-Aldrich,
shRNA from
Sigma-Aldrich,
OriGene,
Tagged/untagged cDNA clones from
OriGene, Expression Assays from Applied Biosystems) About This Section
|               OriGene 29mer shRNA kit in GFP-retroviral vector: NM_000137
Sigma-Aldrich siRNA and siRNA Panels for FAH  Sigma-Aldrich shRNA for FAH  Explore Sigma-Aldrich super-pooled esiRNAs 
Applied Biosystems Silencer® siRNAs: NM_000137 REFSEQ mRNAs for FAH gene: NM_000137.1
Applied Biosystems TaqMan ® Gene Expression Assays: NM_000137               OriGene GFP tagged cDNA clone in CMV expression vector: NM_000137                                  Myc/DDK tagged cDNA clone in CMV expression vector: NM_000137                                  untagged cDNA clone in CMV expression vector: NM_000137  Additional cDNA sequence: AK297965.1 AK313951.1 AL109715.1 BC002527.1 BT007160.1 CR593179.1 CR600618.1 CR603970.1 CR605525.1 CR612848.1 CR617015.1 CR623289.1 CR624063.1 M55150.1 S63548.1 S63549.1 X51728.1 13 DOTS entries: DT.447875 DT.100809263 DT.410206 DT.101983859 DT.86854754 DT.100000922 DT.100784112 DT.100025822 DT.100689240 DT.121054506 DT.100025821 DT.100663465 DT.97846191 24/281 AceView cDNA sequences (see all 281
):BQ052266 BQ051988 BG033965 BE514002 BX117399 AL598665 BP340208 NM_000137 BE326748 AA700567 BC002527 CR612848 AI057453 CR624063 BG491713 AA777366 BG477285 AW444672 H57100 BQ229474 AI347512 BQ052148 CR605525 BM126301
highest scoring ESTs for FAH:M55150 AA101494 AA534626 AA534645 AA555140 AA555264 AA652439 AA777102 AA946814 AA969802 Unigene Cluster for FAH: Fumarylacetoacetate hydrolase (fumarylacetoacetase) Hs.73875 [show with all ESTs]Unigene Representative Sequence: CR605525
GeneLoc Exon Structure
5/8 Alternative Splicing Database (ASD) splice patterns (SP) for FAH (see all 8
)
| ExUns: | 1a | · | 1b | ^ | 2a | · | 2b | · | 2c | ^ | 3 | ^ | 4 | ^ | 5 | ^ | 6a | · | 6b | ^ | 7a | · | 7b | · | 7c | · | 7d | ^ | 8 | ^ | 9 | ^ | 10a | · | 10b | ^ | 11a | · | 11b | ^ | 12 | ^ | 13a | · | 13b | ^ | 14a | · | 14b | ^ | 15a | · | |
| SP1: | |   | |   | |   | |   | |   | |   | |   | - |   | |   | - |   | |   | - |   | - |   | - |   | |   | |   | |   | |   | |   | - |   | |   | - |   | |   | |   | - |   | |   | |
| SP2: | |   | |   | |   | |   | |   | |   | |   | |   | |   | - |   | |   | - |   | - |   | - |   | |   | |   | |   | |   | |   | - |   | |   | |   | |   | |   | |   | |   | |
| SP3: | |   | |   | - |   | - |   | |   | |   | |   | - |   | |   | - |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |
| SP4: | |   | |   | - |   | - |   | |   | |   | |   | - |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |
| SP5: | |   | |   | |   | |   | |   | |   | |   | - |   | |   | - |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   | |   |
| ExUns: | 15b | ^ | 16a | · | 16b | |
| SP1: | |   | |   | |   | |
| SP2: | |   | |   | |   | |
| SP3: | |   | |   | |   | |
| SP4: | |   | |   | |   | |
| SP5: | |   | |   | |   |
About this scheme
ECgene alternative splicing isoforms for FAH
2 Ensembl transcripts including schematic representations: ENST00000261755
ENST00000407106
|
Expression for FAH
(Experimental results according to
1GeneNote
and GNF BioGPS,
probe sets-to-genes annotations according to
2GeneAnnot ,
3GeneTide ,
Sets of similar genes according to GeneDecks,
Electronic Northern calculations according to data from
UniGene (Build 219 Homo sapiens),
SAGE tags according to
CGAP,
plus additional links to
SOURCE, and/or
GNF
BioGPS, and/or
EXPOLDB, and/or
UniProtKB,
Expression Assays from
Applied Biosystems
)
About This Section
| FAH expression in normal and diseased human tissues
Applied Biosystems TaqMan ® Gene Expression Assays for FAH
1 / 2 / 3 4 probe-sets matching FAH gene Data from
(Publications) and GNF BioGPS About these images About these images
CGAP SAGE TAG: AGATTTTCTC
SOURCE GeneReport for Unigene cluster: Hs.73875
Expression variation in blood from EXPOLDB for FAH UniProtKB/Swiss-Prot: FAAA_HUMAN, P16930Tissue specificity: Mainly in liver and kidney. Lower levels are also detected in many other tissues |
Orthologs for FAH
(Orthologs according to
1,2HomoloGene (2older version, for species not in 1newer version),
3euGenes,
4SGD
and/or
5MGI Jun 06 2009,
with possible further links to
Flybase
and/or
WormBase,
Gene Trees according to Ensembl)
About This Section
|
Orthologs for FAH gene from 5/22 species (see all 22
)
About this table Species with no ortholog for FAH
ENSEMBL Gene Tree for FAH | Paralogs for FAH(Paralogs according to 1HomoloGene and 2Ensembl, Pseudogenes according to 3Pseudogene.org) About This Section
| -- |
SNPs/Variants for FAH(According to the
1NCBI SNP Database,
2Ensembl,
3PupaSUITE, and
UniProtKB,
Linkage Disequilibrium by HapMap,
Genotyping Reagents from
Applied Biosystems)
About This Section
|
HapMap Linkage Disequilibrium images for FAH (up to first 250kb)
|
Disorders & Mutations for FAH
(in which this Gene is Involved, According to
OMIM, UniProtKB,
Novoseek, PharmGKB,
Genatlas, GeneTests,
Blood group antigen gene mutations by BGMUT,
HGMD, GAD,
HuGE Navigator,
BCGD,
and/or TGDB.)
About This Section
|
OMIM: 276700 UniProtKB/Swiss-Prot: FAAA_HUMAN, P16930
Defects in FAH are the cause of tyrosinemia type 1 (TYRO1) [MIM:276700]. TYRO1 is an inborn error of metabolism characterized by elevations of tyrosine in the blood and urine, and hepatorenal manifestations. Typical features include hepatic necrosis, renal tubular injury, episodic weakness, self-mutilation, and seizures. Renal tubular dysfunction is associated with phosphate loss and hypophosphataemic rickets. Progressive liver disease can lead to the development of hepatocellular carcinoma. Dietary treatment with restriction of tyrosine and phenylalanine alleviates the rickets, but liver transplantation has so far been the only definite treatment. TYRO1 is a rare condition, except in the Saguenay-lac-St-Jean region (province of Quebec, Canada) where the frequency is high as the result of a founder effect10/14 Novoseek disease relationships for FAH gene (see all 14
)
| Disease |
Score |
Articles |
PubMed IDs for Articles with Shared Sentences (# sentences) |
| tyrosinemia type i |
98.39 |
49 |
12203990 (2), 7702626 (2), 8318997 (2), 8473520 (2) (see all 31) |
| tyrosinemias |
98.10 |
67 |
2378356 (4), 8005583 (2), 8364576 (2), 7550234 (2) (see all 35) |
| tyrosinemia type ii |
80.92 |
1 |
7616655 (1) |
| rickets |
70.69 |
1 |
11701644 (1) |
| metabolic disorder |
68.29 |
18 |
11154690 (2), 8162054 (2), 11209059 (1), 7545495 (1) (see all 10) |
| hepatocellular carcinoma |
63.75 |
3 |
11196105 (1), 11476670 (1), 9305902 (1) |
| liver failure |
63.65 |
2 |
1297646 (1), 11196105 (1) |
| genetic disorder |
62.14 |
16 |
16899383 (1), 8253377 (1), 11532983 (1), 16414314 (1) (see all 11) |
| alkaptonuria |
59.59 |
1 |
7568087 (1) |
| liver diseases |
52.37 |
7 |
8589717 (1), 8253377 (1), 1644288 (1), 11196105 (1) |
About this table
Genatlas disease: FAH tyrosinemia I,hepatorenal GeneTests: FAH Tyrosinemia Type I Human Gene Mutation Database: FAH Human Genome Epidemiology Navigator: FAH (11 documents)
|
Medical News for FAH(Possibly Related Articles in
Doctor's Guide)
About This Section
| |
Publications for FAH (in
PubMed.
Associations of this gene to articles via
1Novoseek,
2HGNC,
3Entrez Gene,
4UniProtKB/Swiss-Prot,
5UniProtKB/TrEMBL,
6GAD, and/or
7PharmGKB)
About This Section
| 10/115 PubMed articles for FAH gene (see all 115
):- Cloning and expression of the cDNA encoding human fumarylacetoacetate hydrolase, the enzyme deficient in hereditary tyrosinemia: assignment of the gene to chromosome 15. (PubMed id 1998338)1, 2, 3, 4 Phaneuf D....Tanguay R.M. (1991)
- Nucleotide sequence of cDNA encoding human fumarylacetoacetase. (PubMed id 2336361)1, 2, 3, 4 Agsteribbe E....Berger R. (1990)
- Type 1 hereditary tyrosinemia. Evidence for molecular heterogeneity and identification of a causal mutation in a French Canadian patient. (PubMed id 1401056)1, 3, 4 Phaneuf D....Tanguay R.M. (1992)
- Structural and functional analysis of missense mutations in fumarylacetoacetate hydrolase, the gene deficient in hereditary tyrosinemia type 1. (PubMed id 11278491)1, 3, 4 Bergeron A.... Tanguay R.M. (2001)
- Hereditary tyrosinemia type 1: novel missense, nonsense and splice consensus mutations in the human fumarylacetoacetate hydrolase gene; variability of the genotype-phenotype relationship. (PubMed id 8557261)1, 3, 4 Ploos van Amstel J.K.... Berger R. (1996)
- Two missense mutations causing tyrosinemia type 1 with presence and absence of immunoreactive fumarylacetoacetase. (PubMed id 8005583)1, 3, 4 Rootwelt H....Kvittingen E.A. (1994)
- Characterization of the human fumarylacetoacetate hydrolase gene and identification of a missense mutation abolishing enzymatic activity. (PubMed id 8364576)1, 3, 4 Labelle Y.... Tanguay R.M. (1993)
- Identification of a frequent pseudodeficiency mutation in the fumarylacetoacetase gene, with implications for diagnosis of tyrosinemia type I. (PubMed id 7977370)1, 3, 4 Rootwelt H.... Kvittingen E.A. (1994)
- Mutations in the fumarylacetoacetate hydrolase gene causing hereditary tyrosinemia type I: overview. (PubMed id 9101289)1, 3, 4 St Louis M. and Tanguay R.M. (1997)
- Heterozygosity for an exon 12 splicing mutation and a W234G missense mutation in an American child with chronic tyrosinemia type 1. (PubMed id 7550234)1, 3, 4 Hahn S.H.... Gahl W.A. (1995)
|
Search for FAH
(in PubMed,
OMIM, and NCBI Bookshelf) About This Section
|
|
Genome Databases showing FAH
(According to
Entrez Gene,
HGNC,
AceView,
euGenes,
Ensembl,
miRBase,
ECgene,
and/or
H-InvDB)
About This Section
|
| Other Databases showing FAH
(According to HUGE)
About This Section
| -- |
Specialized Databases showing FAH(According to ATLAS, HORDE, IMGT, MTDB, LEIDEN, UniProtKB/Swiss-Prot, and/or UniProtKB/TrEMBL, Wikipedia and/or GeneReviews via UniProtKB/Swiss-Prot) About This Section
|
| Name | Description |
| GeneReviews | http://www.genetests.org/query?gene=FAH |
|
| | | About This Section
| --
| Services for FAH(Reagents available from Applied Biosystems, Antibodies and assays by Cell
Signaling Technology, Abcam, Novus Biologicals, Sigma-Aldrich, R&D Systems, Millipore, Abnova, and/or Invitrogen, Clones available from OriGene,and/or Invitrogen, Drugs and/or compounds by Sigma-Aldrich, Enzo Life Sciences, and/or Tocris Bioscience) About This Section
| 
 Products for FAH:

 | |
 | | | | |
|
 |  |  |
| | | | Search Tocris compounds for FAH |
|
 |
 | | | Antibodies for FAH |
| |
GeneCards Homepage - Last full update: 1 Jul 2009
Incremental update: 13 Oct 2009
|